NCT07022938CompletedPhase 4
Nutritional Supplement for Treating Chemotherapy Induced Neuropathy
Efficacy and Safety of a Tablet Containing Palmitoyethanolamide, Alpha Lipoic Acid, Vitamin B12, Vitamin B6 , Vitamin B1, Nicotinamide, Magnesium, Zinc, Vitamin E, and Superoxide of Dismutase in Individuals Receiving Chemotherapy
Source: ClinicalTrials.gov · Last updated 26 Dec 2025
Brief summary (registry, in English)
Administration of a nutritional supplement containing palmitoyethanolamide, alpha lipoic acid, vitamin B12, vitamin B6 , vitamin B1, nicotinamide, magnesium, zinc, vitamin E, and superoxide of dismutase in individuals receiving chemotherapy
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 71 (actual)
- First submitted
- 8 Jun 2025
- Start date
- 1 Nov 2021
- Primary completion date
- 31 Jan 2025
- Lead sponsor
- Aristotle University Of Thessaloniki
- Diseases
- Childhood cancers
- NCT number
- NCT07022938
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 71
- From 1 Nov 2021 to the primary completion date, 31 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not receiving dietary supplement
- Have already started chemotherapy
Other illness
- Patients with uncontrolled diabetes
- \-- Patients with chronic kidney disease
Other
- Have already neuropathy
- Patiens with recent cardiovascular incident
Who the study is looking for
- Newly diagnosed patients with cancer that have not received yet their treatment
- Patients that will be treated with platinum agents or taxanes
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University General Hospital of Thessaloniki - AHEPA Coordinator of this site? Confirm its status | Thessaloniki | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.